|
(P1418) |
PEPCAD-DES: A randomized, multicenter, single blinded trial comparing paclitaxel coated balloon angioplasty with plain balloon angioplasty in drug-eluting-stent restenosis – 36 months results |
| |
|
H. Rittger, M. Waliszewski, W. G. Daniel, S. Achenbach, J. Brachmann, J. Wöhrle (Fürth, Berlin, Erlangen, Coburg, Ulm) |
|
(P1419) |
Long-term follow-up of a randomized trial of polymer-free sirolimus- and probucol-eluting stents versus durable polymer zotarolimus-eluting stents |
| |
|
S. Kufner, J. Sorges, J. Mehilli, S. Cassese, J. Repp, J. Wiebe, R. Lohaus, A. Lahmann, T. Rheude, T. Ibrahim, S. Massberg, K.-L. Laugwitz, S. Massberg, A. Kastrati , ISAResearch Center (München) |
|
(P1420) |
Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 30 days and 6-month Results from the DESolve PMCF Study |
| |
|
H. Nef, K. E. Hauptmann, D. Fischer, T. K. Rudolph, G. Richardt, O. Dörr, J. Wiebe, C. W. Hamm (Gießen, Trier, Münster, Köln, Bad Segeberg, München) |
|
(P1421) |
Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice – Results of the ISAR-ABSORB Registry |
| |
|
P. Hoppmann, S. Kufner, S. Cassese, J. Wiebe, S. Schneider, M. I. Bernlochner, H. Schunkert, K.-L. Laugwitz, A. Kastrati, R. Byrne (München) |
|
(P1422) |
Propensity score matching analysis of currently available bioresorbable scaffolds in the clinical setting of ACS |
| |
|
O. Dörr, J. Wiebe, C. Liebetrau, H. Möllmann, N. F. Boeder, H. Ilstad, A. Elsässer, T. Bauer, C. W. Hamm, H. Nef (Gießen, München, Bad Nauheim, Oldenburg, Giessen) |
|
(P1423) |
Does metallic stent design influence acute and longterm clinical outcome in second generation Everolimus-Eluting stents ? Results of a single-center, 2-phase all-comer stent registry |
| |
|
T. Schlegel, M. Steeg, S. Fateh-Moghadam, T. Geisler, H. Langer, P. Seizer, M. Gawaz, W. Bocksch (Tübingen) |